Useful immunohistochemical panel for differentiating clear cell papillary renal cell carcinoma from its mimics

Annals of Diagnostic Pathology

Volumn 17, Issue 5, 2013, Pages 437-440

  Pramick, Michelle ^a   Ziober, Amy ^a   Bing, Zhanyong ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Sanford Broadway Clinic   (United States)

Author keywords

AMACR; CA IX; CK7; Clear cell papillary renal cell carcinoma; PAX8

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CARBONATE DEHYDRATASE IX; CYTOKERATIN 7; TRANSCRIPTION FACTOR PAX8;

ADULT; AGED; ARTICLE; CANCER SIZE; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; CLINICAL ARTICLE; CYTOPLASM; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMACR; CA IX; CK7; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; PAX8;

ADULT; AGED; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84884289993     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.05.004     Document Type: Article

References (30)

1. H. Aydin, L. Chen, L. Cheng, S. Vaziri, H. He, and R. Ganapathi Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney Am J Surg Pathol 34 11 2010 1608 1621
2. S. Gobbo, J.N. Eble, D.J. Grignon, G. Martignoni, G.T. MacLennan, and R.B. Shah Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity Am J Surg Pathol 32 8 2008 1239 1245
3. H. Ross, G. Martignoni, and P. Argani Renal cell carcinoma with clear cell and papillary features Arch Pathol Lab Med 136 4 2012 391 399
4. S.K. Tickoo, M.N. dePeralta-Venturina, L.R. Harik, H.D. Worcester, M.E. Salama, and A.N. Young AN Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia Am J Surg Pathol 30 2 2006 141 153
5. C.G. Li, and M.R. Eccles PAX genes in cancer; friends or foes? Front Genet 3 2012 6
6. V. Frost, T. Grocott, M.R. Eccles, and A. Chantry Self-regulated Pax gene expression and modulation by the TGFbeta superfamily Crit Rev Biochem Mol Biol 43 6 2008 371 391
7. A. Ozcan, S.S. Shen, C. Hamilton, K. Anjana, D. Coffey, and B. Krishnan PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study Mod Pathol 24 6 2011 751 764
8. G.X. Tong, W.M. Yu, N.T. Beaubier, E.M. Weeden, D. Hamele-Bena, and M.M. Mansukhani Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study Mod Pathol 22 9 2009 1218 1227
9. B.A. Alexiev, and C.M. LeVea Nephrogenic adenoma of the urinary tract: a review Int J Surg Pathol 20 2 2012 123 131
10. J.C. Carvalho, D.G. Thomas, J.B. McHugh, R.B. Shah, and L.P. Kunju p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system Histopathology 60 4 2012 597 608
11. Y. Hu, A. Hartmann, C. Stoehr, S. Zhang, M. Wang, and D. Tacha PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody J Clin Pathol 65 3 2012 254 256
12. S.M. Knoepp, L.P. Kunju, and M.H. Roh Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology Diagn Cytopathol 40 8 2012 667 672
13. A.R. Laury, R. Perets, H. Piao, J.F. Krane, J.A. Barletta, and C. French A comprehensive analysis of PAX8 expression in human epithelial tumors Am J Surg Pathol 35 6 2011 816 826
14. D. Tacha, W. Qi, D. Zhou, R. Bremer, and L. Cheng PAX8 mouse monoclonal antibody [BC12] recognizes a restricted epitope and is highly sensitive in renal cell and ovarian cancers but does not cross-react with B cells and tumors of pancreatic origin Appl Immunohistochem Mol Morphol 21 1 2013 59 63
15. J. Adam, J. Couturier, V. Molinie, A. Vieillefond, and M. Sibony Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases Histopathology 58 7 2011 1064 1071
16. J.M. Hagenkord, Z. Gatalica, E. Jonasch, and F.A. Monzon Clinical genomics of renal epithelial tumors Cancer Genet 204 6 2011 285 297
17. N. Kuroda, C. Ohe, S. Mikami, K. Inoue, Y. Nagashima, and R.J. Cohen Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects Histol Histopathol 27 8 2012 969 974
18. E.M. Genega, M. Ghebremichael, R. Najarian, Y. Fu, Y. Wang, and P. Argani Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade Am J Clin Pathol 134 6 2010 873 879
19. S. Ivanov, S.Y. Liao, A. Ivanova, A. Danilkovitch-Miagkova, N. Tarasova, and G. Weirich Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer Am J Pathol 158 3 2001 905 919
20. S.Y. Liao, O.N. Aurelio, K. Jan, J. Zavada, and E.J. Stanbridge Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney Cancer Res 57 14 1997 2827 2831
21. E. Oosterwijk, D.J. Ruiter, P.J. Hoedemaeker, E.K. Pauwels, U. Jonas, and J. Zwartendijk Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney Int J Cancer 38 4 1986 489 494
22. Z. Bing, P. Lal, S. Lu, A. Ziober, and J.E. Tomaszewski Role of carbonic anhydrase IX, alpha-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study Ann Diagn Pathol 17 1 2013 58 62
23. V.E. Reuter, and S.K. Tickoo Differential diagnosis of renal tumours with clear cell histology Pathology 42 4 2010 374 383
24. M.D. Lloyd, D.J. Darley, A.S. Wierzbicki, and M.D. Threadgill Alpha-methylacyl-CoA racemase - an "obscure" metabolic enzyme takes centre stage FEBS J 275 6 2008 1089 1102
25. F. Lin, R.E. Brown, T. Shen, X.J. Yang, and C. Schuerch Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas Appl Immunohistochem Mol Morphol 12 2 2004 153 159
26. M.H. Tan, C.F. Wong, H.L. Tan, X.J. Yang, J. Ditlev, and D. Matsuda Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma BMC Cancer 10 2010 196
27. M.H. Tan, C. Morrison, P. Wang, X. Yang, C.J. Haven, and C. Zhang Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma Clin Cancer Res 10 19 2004 6629 6637
28. S.M. Gilani, R. Tashjian, and H. Qu Clear cell papillary renal cell carcinoma with characteristic morphology and immunohistochemical staining pattern Pathologica 104 3 2012 101 104
29. S.S. Shen, L.D. Truong, M. Scarpelli, and A. Lopez-Beltran Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? Arch Pathol Lab Med 136 4 2012 410 417
30. J.C. Carvalho, M.J. Wasco, L.P. Kunju, D.G. Thomas, and R.B. Shah Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics Histopathology 58 2 2011 169 179